vimarsana.com
Home
Live Updates
Can MS Be Stopped Early in its Tracks? : vimarsana.com
Can MS Be Stopped Early in its Tracks? : vimarsana.com
Can MS Be Stopped Early in its Tracks?
The first randomized trial of a disease-modifying therapy in radiological isolated syndrome, the earliest pre-clinical phase of MS, suggests dimethyl fumarate reduced the risk of a first clinical event by 80%.
Related Keywords
California ,
United States ,
Santa Monica ,
Dallas ,
Texas ,
University Of Texas Southwestern Medical Center ,
Amsterdam ,
Noord Holland ,
Netherlands ,
Celgene Bristol Myers Squibb ,
Viela Bio ,
Barbara Giesser ,
Darin Okuda ,
Serono Merck ,
Genentech ,
Pacific Neuroscience Institute In Santa Monica ,
Novartis ,
Janssen Pharmaceuticals ,
Osmotica Pharmaceuticals ,
Serono ,
Research In Multiple Sclerosis ,
European Committee For Treatment ,
Texas Southwestern Medical Center ,
European Committee ,
Multiple Sclerosis ,
Medscape Medical News ,
Pacific Neuroscience Institute ,
Bristol Myers Squibb ,
Multiple Sclerosis Ms ,
Us ,
Ms Lesion ,
Ultiple Sclerosis Lesion ,
Multiple Sclerosis Imaging ,
S Imaging ,
Maging In Multiple Sclerosis ,
Maging In Ms ,
Maging Studies In Multiple Sclerosis ,
Maging Studies In Ms ,
Multiple Sclerosis Progression ,
Als Progression ,
Multiple Sclerosis Treatment ,
Als Treatment ,
Reatment Of Multiple Sclerosis ,
Reatment Of Ms ,
Disease Modifying Therapy ,
,